Ropark 0.5 mg (Ropinirole) Quantity:120 Tablet/s Not for patients with Type

Not for patients with Type 1 Diabetes or diabetic ketoacidosis

Regular monitoring of blood pressure and cardiac status is advisable for those with pre‑existing cardiovascular risk factors

or signs of jaundice (such as yellowing of the skin or eyes) to their healthcare provider promptly

Subcutaneous Injection Sites: Inject into the shallow fat layer of the abdomen

The Performance Window: Provides a continuous

Ropark 0.5 mg (Ropinirole) Quantity:120 Tablet/s Not for patients with TypeProduct Overview Ropark 0. 5 mg is a prescription medication that contains the active ingredient ropinirole. It is manufactured by Sun Pharmaceutical Industries Ltd and is supplied in a strip of ten tablets. This product is indicated for the treatment of Parkinsons disease and for the relief of symptoms associated with restless leg syndrome (RLS). Ropinirole belongs to the class of nonerosive dopamine agonists that work by stimulating dopamine